EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal Cancer

✍ Scribed by Sobrero, A. F.; Maurel, J.; Fehrenbacher, L.; Scheithauer, W.; Abubakr, Y. A.; Lutz, M. P.; Vega-Villegas, M. E.; Eng, C.; Steinhauer, E. U.; Prausova, J.; Lenz, H.-J.; Borg, C.; Middleton, G.; Kroning, H.; Luppi, G.; Kisker, O.; Zubel, A.; Langer, C.; Kopit, J.; Burris, H. A.

• Book ID: 118139888
• Publisher: American Society of Clinical Oncology
• Year: 2008
• Tongue: English
• Weight: 257 KB
• Volume: 26
• Category: Article
• ISSN: 0732-183X
• DOI: 10.1200/jco.2007.13.1193